source
- FDA holds psychedelic forum as Definium reports third successful Phase 3 trial of oral LSD for anxietyThe FDA convened a public forum on Monday to discuss the near‑term outlook for psychedelic drug development, highlighting interest from companies such as Compass Pathways and Definium Therapeutics.…
- FDA issues warning letter to Bausch & Lomb over aseptic processing concernsFDA sent a warning letter to Bausch & Lomb after inspectors reviewed the company’s response to earlier observations at its Florida plant. The agency said the response did not demonstrate a commitme…